These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6613591)

  • 21. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative structure-activity relationship of reversible dihydrofolate reductase inhibitors. Diaminotriazines.
    Hansch C; Silipo C
    J Med Chem; 1974 Jul; 17(7):661-7. PubMed ID: 4836398
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of dihydrofolate reductase. 3. 4.6-Diamino-1,2-dihydro-2,2-dimethyl-1-(2-substituted-phenyl)-s-triazine inhibition of bovine liver and mouse tumor enzymes.
    Kim KH; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    J Med Chem; 1980 Nov; 23(11):1248-51. PubMed ID: 7452676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytotoxic activity of 1-acyl- and 1,2-diacyl-4,4-diethyl-3,5-pyrazolidinediones.
    Hall IH; Izydore RA; Vital TS; Chen SY; Miller MC; Bernal-Ramirez JA; Okwisa WA; Rajendran KG
    Anticancer Res; 1995; 15(1):199-204. PubMed ID: 7733634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.
    Mauritz R; Bekkenk MW; Rots MG; Pieters R; Mini E; van Zantwijk CH; Veerman AJ; Peters GJ; Jansen G
    Clin Cancer Res; 1998 Oct; 4(10):2399-410. PubMed ID: 9796971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dihydrofolate reductase inhibition. A study in the use of X-ray crystallography, molecular graphics, and quantitative structure-activity relations in drug design.
    Hansch C
    Drug Intell Clin Pharm; 1982 May; 16(5):391-6. PubMed ID: 6806055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irreversible enzyme inhibitors. CLXXVII. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. II.
    Baker BR; Vermeulen NM
    J Med Chem; 1970 Nov; 13(6):1154-60. PubMed ID: 5479856
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative structure-activity relationships by neural networks and inductive logic programming. II. The inhibition of dihydrofolate reductase by triazines.
    Hirst JD; King RD; Sternberg MJ
    J Comput Aided Mol Des; 1994 Aug; 8(4):421-32. PubMed ID: 7815093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dependence on exogenous methionine of rat sarcoma and murine leukemia cells in culture.
    Koziorowska J; Pieńkowska K; Tautt J
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):709-16. PubMed ID: 7212978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible enzyme inhibitors. 108. p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. IV. Effects of substitution on the propionamide bridge on isozyme specificity.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jul; 11(4):672-7. PubMed ID: 5244345
    [No Abstract]   [Full Text] [Related]  

  • 31. Irreversible enzyme inhibitors. CXXVII. p-(2,6-diamino-1,2-dihydro--2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. 3. Effects of modification of the propionamide bridge on isozyme specificity.
    Baker BR; Luorens GJ
    J Med Chem; 1968 Jul; 11(4):666-72. PubMed ID: 5244344
    [No Abstract]   [Full Text] [Related]  

  • 32. Folate inhibitors: a structure-activity analysis using linear modeling.
    Hansch C
    Ann N Y Acad Sci; 1971 Nov; 186():235-47. PubMed ID: 4943575
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.
    Kamchonwongpaisan S; Quarrell R; Charoensetakul N; Ponsinet R; Vilaivan T; Vanichtanankul J; Tarnchompoo B; Sirawaraporn W; Lowe G; Yuthavong Y
    J Med Chem; 2004 Jan; 47(3):673-80. PubMed ID: 14736247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible enzyme inhibitors. CXXIX. p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. V. Effects of substitution on the benzenesulfonyl fluoride moiety on isozyme specificity.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jul; 11(4):677-82. PubMed ID: 5244346
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of retinoids on induction of differentiation of cultured mouse myeloid leukemia cells.
    Takenaga K; Hozumi M; Sakagami Y
    Cancer Res; 1980 Mar; 40(3):914-9. PubMed ID: 6937243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents.
    Gangjee A; Vidwans AP; Vasudevan A; Queener SF; Kisliuk RL; Cody V; Li R; Galitsky N; Luft JR; Pangborn W
    J Med Chem; 1998 Aug; 41(18):3426-34. PubMed ID: 9719595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase.
    Hekmat-Nejad M; Rathod PK
    Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of genistein and amsacrine on leukemia cell proliferation.
    Finlay GJ; Holdaway KM; Baguley BC
    Oncol Res; 1994; 6(1):33-7. PubMed ID: 7919550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced tumorigenicity of murine leukemia cells expressing protein-tyrosine phosphatase, PTPepsilon C.
    Tanuma N; Shima H; Shimada S; Kikuchi K
    Oncogene; 2003 Mar; 22(12):1758-62. PubMed ID: 12660811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
    Gangjee A; Adair OO; Queener SF
    J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.